Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline SubsidiaryFutureBrand Hispanic America onboards Vicapsys and delivers a unified visual identity for Vicapsys Life Sciences and its Stateline subsidiaryTwo linked brands under one visual system: Vicapsys as the umbrella brand and Stateline as the operating brand, now being applied across corporate materials, investor communications, Stateline's commercial documents and packaging, and the Company's public disclosuresThe identity rollout is the first of the Company's post-merger housekeeping steps; its OTCID application, Rule 15c2-11 quotation process and PCAOB audit are underway alongside it
Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline MergerAdvisors bring experience across federal government, tribal governance and economic development, pharmaceutical development and manufacturing, oncology in Puerto Rico, international financial operations, brand strategy and hospital group purchasingAdvisory Board supports management on the Company's federal and tribal channel strategy, the NitroMist® relaunch and the planned Puerto Rico manufacturing facility
RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution PlatformStateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party logistics partner DrugzoneStrategic tribal 8(a) teaming agreement gives the combined company access to set-aside and sole-source federal contracting channels, including Indian Health Service pharmaceutical supplyVICP has signed a definitive agreement to acquire NitroMist® (nitroglycerin) lingual aerosol, NDA 021780, for a US$2.0million convertible note and is preparing stability, medium-fill and pre-production batches with its contract manufacturing partner for the product's relaunchCompany in discussions to acquire an approximately 120,000-square-foot former big-pharma API manufacturing facility in Puerto Rico, including 50,000 square feet of cleanroom manufacturing space and 70,000 square feet of distribution space
Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal,Stateline is a DSCSA-compliant specialty pharmaceutical wholesale distributor with approximately 400 active healthcare accounts in Puerto Rico and a 50-state title model executed through third-party logistics partner DrugzoneStrategic tribal 8(a) teaming agreement gives the combined company access to set-aside and sole-source federal contracting channels, including Indian Health Service pharmaceutical supplyVICP has signed a definitive agreement to acquire NitroMist® (nitroglycerin) lingual aerosol, NDA 021780, for a US$2.0million convertible note and is preparing stability, medium-fill and pre-production batches with its contract manufacturing partner for the product's relaunchCompany in discussions to acquire an approximately 120,000-square-foot former big-pharma API manufacturing facility in Puerto Rico, including 50,000 square feet of cleanroom manufacturing space and 70,000 square feet of distribution space
